Il y a eu 50 transactions d'initiés récentes enregistrées pour SAB Biotherapeutics, Inc. (SABS), dont 38 achats et 8 ventes. Le total des achats d'initiés s'élève à $151.56M et le total des ventes d'initiés à $180.65K.
Les initiés notables ayant une activité récente comprennent Kropotova Alexandra, Reich Samuel J, Sullivan Eddie Joe. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — SABS
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-24 |
Kropotova Alexandra |
Chief Medical Officer |
Retenue Fiscale RSU |
988 |
- |
- |
43,296 |
| 2026-02-03 |
Reich Samuel J |
CEO |
Attribution de RSU |
4,800,000 |
$4.45 |
$21.36M |
4,800,000 |
| 2026-02-03 |
Kropotova Alexandra |
Chief Medical Officer |
Attribution de RSU |
2,400,000 |
$4.45 |
$10.68M |
2,400,000 |
| 2026-02-03 |
Sullivan Eddie Joe |
President |
Attribution de RSU |
3,000,000 |
$4.45 |
$13.35M |
3,000,000 |
| 2026-02-03 |
Bausch Christoph Lawrence |
Chief Operating Officer |
Attribution de RSU |
1,800,000 |
$4.45 |
$8.01M |
1,800,000 |
| 2026-02-03 |
To Lucy |
See Remarks |
Attribution de RSU |
2,400,000 |
$4.45 |
$10.68M |
2,400,000 |
| 2026-01-05 |
Zaccardelli David |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-01-05 |
Zaccardelli David |
Director |
Attribution de RSU |
240,000 |
$3.74 |
$897.6K |
240,000 |
| 2026-01-05 |
Jain Rita |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-01-05 |
Jain Rita |
Director |
Attribution de RSU |
240,000 |
$3.74 |
$897.6K |
240,000 |
| 2025-12-16 |
Skyler Jay S |
Director |
Attribution de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Lucera Erick |
Director |
Attribution de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Polvino William James |
Director |
Attribution de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Giberson Scott |
Director |
Attribution de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Ellias Helen K. |
Director |
Attribution de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Link David |
Director |
Attribution de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-11 |
Kropotova Alexandra |
Chief Medical Officer |
Retenue Fiscale RSU |
988 |
- |
- |
44,284 |
| 2025-09-29 |
Sessa Capital (master), L.p. |
Director |
Exercice d'Options (Vente) |
17,400 |
$1.75 |
$30.45K |
211,100 |
| 2025-09-29 |
Moin Andrew |
Director |
Exercice d'Options (Vente) |
17,400 |
$1.75 |
$30.45K |
211,100 |
| 2025-09-19 |
Kropotova Alexandra |
Chief Medical Officer |
Retenue Fiscale RSU |
1,977 |
- |
- |
45,272 |
| 2025-08-26 |
Reich Samuel J |
CEO & Executive Chairman |
Attribution de RSU |
4,800,000 |
$2.17 |
$10.42M |
4,800,000 |
| 2025-08-26 |
Kropotova Alexandra |
Chief Medical Officer |
Attribution de RSU |
2,400,000 |
$2.17 |
$5.21M |
2,400,000 |
| 2025-08-26 |
Sullivan Eddie Joe |
President |
Attribution de RSU |
3,000,000 |
$2.17 |
$6.51M |
3,000,000 |
| 2025-08-26 |
Bausch Christoph Lawrence |
Chief Operating Officer |
Attribution de RSU |
600,000 |
$2.17 |
$1.3M |
600,000 |
| 2025-08-26 |
To Lucy |
See Remarks |
Attribution de RSU |
1,200,000 |
$2.17 |
$2.6M |
1,200,000 |
| 2025-07-22 |
Sessa Capital (master), L.p. |
Director |
Attribution de RSU |
114,250 |
$218.75 |
$24.99M |
114,250 |
| 2025-07-22 |
Moin Andrew |
Director |
Attribution de RSU |
114,250 |
$218.75 |
$24.99M |
114,250 |
| 2025-03-27 |
Kropotova Alexandra |
Chief Medical Officer |
Retenue Fiscale RSU |
1,179 |
- |
- |
47,249 |
| 2024-12-18 |
Kropotova Alexandra |
Chief Medical Officer |
Retenue Fiscale RSU |
9,072 |
- |
- |
48,428 |
| 2024-11-01 |
Ellias Helen K. |
Director |
Attribution de RSU |
20,000 |
$3.88 |
$77.6K |
20,000 |
| 2024-08-12 |
To Lucy |
See Remarks |
Attribution de RSU |
125,000 |
$2.35 |
$293.75K |
125,000 |
| 2024-07-26 |
To Lucy |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-07-15 |
Hamilton Christine E |
Director |
Attribution de RSU |
2,326 |
$2.90 |
$6.75K |
2,326 |
| 2024-07-15 |
Skyler Jay S |
Director |
Attribution de RSU |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Reich Samuel J |
CEO & Executive Chairman |
Attribution de RSU |
35,700 |
$2.90 |
$103.53K |
35,700 |
| 2024-07-15 |
Spragens Jeffrey G |
Director |
Attribution de RSU |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Lucera Erick |
Director |
Attribution de RSU |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Polvino William James |
Director |
Attribution de RSU |
13,958 |
$2.90 |
$40.48K |
13,958 |
| 2024-07-15 |
Link David Charles |
Director |
Attribution de RSU |
9,305 |
$2.90 |
$26.98K |
9,305 |
| 2024-07-15 |
Sullivan Eddie Joe |
President |
Attribution de RSU |
4,447 |
$2.90 |
$12.9K |
4,447 |
| 2024-07-15 |
Giberson Scott |
Director |
Attribution de RSU |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-06-04 |
Conley Mark William |
See Remarks |
Cession |
25,000 |
$4.79 |
$119.75K |
- |
| 2024-05-03 |
Skyler Jay S |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-02-21 |
Reich Samuel J |
CEO & Executive Chairman |
Attribution de RSU |
434,000 |
$5.17 |
$2.24M |
434,000 |
| 2024-02-21 |
Kropotova Alexandra |
Chief Medical Officer |
Attribution de RSU |
140,000 |
$5.17 |
$723.8K |
140,000 |
| 2024-02-21 |
Sullivan Eddie Joe |
President |
Attribution de RSU |
190,000 |
$5.17 |
$982.3K |
190,000 |
| 2024-02-21 |
Bausch Christoph Lawrence |
Chief Operating Officer |
Attribution de RSU |
140,000 |
$5.17 |
$723.8K |
140,000 |
| 2024-02-21 |
King Michael |
Chief Financial Officer |
Attribution de RSU |
115,000 |
$5.17 |
$594.55K |
115,000 |
| 2023-12-07 |
Sullivan Eddie Joe |
Chief Executive Officer |
Achat Informatif |
1,740 |
$0.88 |
$1.53K |
5,232,304 |
| 2023-11-30 |
King Michael |
Chief Financial Officer |
Achat Informatif |
5,000 |
$0.90 |
$4.5K |
5,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
